Literature DB >> 19494310

Crucial role of TNF receptors 1 and 2 in the control of polymicrobial sepsis.

Thomas Secher1, Virginie Vasseur, Didier Marc Poisson, Jane A Mitchell, Fernando Q Cunha, José Carlos Alves-Filho, Bernhard Ryffel.   

Abstract

Sepsis is still a major cause of mortality in the intensive critical care unit and results from an overwhelming immune response to the infection. TNF signaling pathway plays a central role in the activation of innate immunity in response to pathogens. Using a model of polymicrobial sepsis by i.p. injection of cecal microflora, we demonstrate a critical role of TNFR1 and R2 activation in the deregulated immune responses and death associated with sepsis. A large and persistent production of TNF was found in wild-type (B6) mice. TNFR1/R2-deficient mice, compared with B6 mice, survive lethal polymicrobial infection with enhanced neutrophil recruitment and bacterial clearance in the peritoneal cavity. Absence of TNFR signaling leads to a decreased local and systemic inflammatory response with diminished organ injury. Furthermore, using TNFR1/R2-deficient mice, TNF was found to be responsible for a decrease in CXCR2 expression, explaining reduced neutrophil extravasation and migration to the infectious site, and in neutrophil apoptosis. In line with the clinical experience, administration of Enbrel, a TNF-neutralizing protein, induced however only a partial protection in B6 mice, with no improvement of clinical settings, suggesting that future TNF immunomodulatory strategies should target TNFR1 and R2. In conclusion, the present data suggest that the endogenous TNFR1/R2 signaling pathway in polymicrobial sepsis reduces neutrophil recruitment contributing to mortality and as opposed to pan-TNF blockade is an important therapeutic target for the treatment of polymicrobial sepsis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494310     DOI: 10.4049/jimmunol.0804008

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Pleiotropic regulations of neutrophil receptors response to sepsis.

Authors:  Huafeng Zhang; Bingwei Sun
Journal:  Inflamm Res       Date:  2016-09-30       Impact factor: 4.575

2.  Gastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: involvement of toll-like receptor 4 signaling.

Authors:  Fabricia Petronilho; Francieli Vuolo; Letícia Selinger Galant; Larissa Constantino; Cristiane Damiani Tomasi; Vinicius Renne Giombelli; Cláudio Teodoro de Souza; Sabrina da Silva; Denise Frediani Barbeiro; Francisco Garcia Soriano; Emílio Luiz Streck; Cristiane Ritter; Alfeu Zanotto-Filho; Matheus Augusto Pasquali; Daniel Pens Gelain; José Luiz Rybarczyk-Filho; José Cláudio Fonseca Moreira; Norman L Block; Rafael Roesler; Gilberto Schwartsmann; Andrew V Schally; Felipe Dal-Pizzol
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

3.  Shedding of tumor necrosis factor receptor 1 induced by protein A decreases tumor necrosis factor alpha availability and inflammation during systemic Staphylococcus aureus infection.

Authors:  Constanza Giai; Cintia Gonzalez; Camila Ledo; Ailin Garofalo; María Silvia Di Genaro; Daniel O Sordelli; Marisa I Gomez
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

4.  Toll-like Receptor 7 Contributes to Inflammation, Organ Injury, and Mortality in Murine Sepsis.

Authors:  Wenling Jian; Lili Gu; Brittney Williams; Yan Feng; Wei Chao; Lin Zou
Journal:  Anesthesiology       Date:  2019-07       Impact factor: 7.892

5.  A novel small molecule, HK-156, inhibits lipopolysaccharide-induced activation of NF-κB signaling and improves survival in mouse models of sepsis.

Authors:  Jian-Ping Fang; Yang Liu; Jie Li; Wen-Feng Liao; You-Hong Hu; Kan Ding
Journal:  Acta Pharmacol Sin       Date:  2012-06-11       Impact factor: 6.150

6.  Hemoadsorption reprograms inflammation in experimental gram-negative septic peritonitis: insights from in vivo and in silico studies.

Authors:  Rami A Namas; Rajaie Namas; Claudio Lagoa; Derek Barclay; Qi Mi; Ruben Zamora; Zhiyong Peng; Xiaoyan Wen; Morgan V Fedorchak; Isabella E Valenti; William J Federspiel; John A Kellum; Yoram Vodovotz
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

7.  Is there a role of TNFR1 in acute lung injury cases associated with extracorporeal circulation?

Authors:  Yu Zhao; Chong-wei Zhang; Wen-jing Zhou; Jiao Chen; Nan-fu Luo; Li-na Gong; Lei Du; Jing Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2014-03       Impact factor: 3.066

8.  Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis.

Authors:  Peter Newham; Daniel Ross; Peter Ceuppens; Shampa Das; James W T Yates; Catherine Betts; Jaimini Reens; Kevin J Randall; Richard Knight; Jennifer S McKay
Journal:  Inflamm Res       Date:  2013-11-17       Impact factor: 4.575

9.  Neutrophil paralysis in Plasmodium vivax malaria.

Authors:  Fabiana Maria de Souza Leoratti; Silvia Cellone Trevelin; Fernando Queiroz Cunha; Bruno Coelho Rocha; Pedro Augusto Carvalho Costa; Humberto Doriguêtto Gravina; Mauro Shugiro Tada; Dhelio Batista Pereira; Douglas Taylor Golenbock; Lis Ribeiro do Valle Antonelli; Ricardo T Gazzinelli
Journal:  PLoS Negl Trop Dis       Date:  2012-06-26

10.  Genetic variation in the TNF gene is associated with susceptibility to severe sepsis, but not with mortality.

Authors:  Zhenju Song; Yuanlin Song; Jun Yin; Yao Shen; Chenling Yao; Zhan Sun; Jinjun Jiang; Duming Zhu; Yong Zhang; Qinjun Shen; Lei Gao; Chaoyang Tong; Chunxue Bai
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.